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Gout is an inflammatory arthritis characterized by the deposition of monosodium urate
crystals in the synovial membrane, articular cartilage and periarticular tissues leading to
inflammation. Men are more commonly affected, mainly after the 5th decade of life. Its
incidence has been growing with the population aging.
In the majority of the cases, the diagnosis is made by clinical criteria and synovial fluid
analysis, in search for monosodium urate crystals. Nonetheless, gout may sometimes have
atypical presentations, complicating the diagnosis. In these situations, imaging methods
have a fundamental role, aiding in the diagnostic confirmation or excluding other possible
differential diagnosis.
Conventional radiographs are still the most commonly used method in gout patients’
evaluation; nevertheless, this is not a sensitive method, since it detect only late alterations.
In  the last years, there have been several advances in imaging methods for gout patients.
Ultrasound has shown a great accuracy in the diagnosis of gout, identifying monosodium
urate deposits in the synovial membrane and articular cartilage, in detecting and character-
izing tophi and in identifying tophaceous tendinopathy and enthesopathy. Ultrasound has
also  been able to show crystal deposition in patients with articular pain in the absence of a
classical gout crisis.
Computed tomography is an excellent method for detecting bone erosions, being use-ful  in spine involvement. Dual-energy CT is a new method able to provide information
about the chemical composition of tissues, with high accuracy in the identification of
eposits, even in the early stages of the disease and in cases of difficultmonosodium urate dcharacterization.
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Magnetic resonance imaging is useful in the evaluation of deep tissues not accessible by
ultrasound.
Besides the diagnosis, with the emergence of new drugs that aim to reduce tophaceous
burden, imaging methods have become useful tools in monitoring the treatment of patients
with gout.
© 2016 Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Aspectos  relevantes  do  diagnóstico  e  seguimento  por  imagem  na  gota
Palavras-chave:
Gota
Ultrassonografia
Ressonância magnética
Tomografia computadorizada de
dupla energia
r  e  s  u  m  o
A gota é uma artrite caracterizada pela deposic¸ão de cristais de monourato sódico na mem-
brana sinovial, na cartilagem articular e nos tecidos periarticulares que leva a um processo
inflamatório.
Na  maioria dos casos o diagnóstico é estabelecido por critérios clínicos e pela análise
do  líquido sinovial, em busca dos cristais de MSU. Porém, a gota pode se manifestar de
maneiras atípicas e dificultar o diagnóstico. Nessas situac¸ões, os exames de imagem têm
papel fundamental, auxiliam na confirmac¸ão diagnóstica ou ainda excluem outros diagnós-
ticos  diferenciais.
A radiografia convencional ainda é o método mais usado no acompanhamento desses
pacientes, porém é um exame pouco sensível, por detectar somente alterac¸ões tardias.
Nos  últimos anos, surgiram avanc¸os nos métodos de imagem em relac¸ão à gota. O ultra-
ssom se mostra um exame de grande acurácia no diagnóstico de gota, identifica depósitos
de  MSU na cartilagem articular e nos tecidos periarticulares e detecta e caracteriza tofos,
tendinopatias e entesopatias por tofos.
A  tomografia computadorizada é um ótimo exame para a detecc¸ão de erosões ósseas
e  avaliac¸ão do acometimento na coluna. A tomografia computadorizada de dupla-energia,
um método novo, fornece informac¸ões sobre a composic¸ão química dos tecidos, permite a
identificac¸ão dos depósitos de MSU com elevada acurácia.
A ressonância magnética pode ser útil na avalic¸ão dos tecidos profundos, não acessíveis
ao  ultrassom.
Além do diagnóstico, com o surgimento de drogas que visam reduzir a carga tofácea,
os  exames de imagem se tornam uma ferramenta útil no acompanhamento do tratamento
dos  pacientes com gota.
© 2016 Publicado por Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma
c¸a  CC
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out is an inflammatory arthritis, characterized by periods of
yperuricemia and deposition of mono sodium urate (MSU)
n the articular cartilage, subchondral bone, synovium, cap-
ule, periarticular tissues and in lower temperature areas such
s the superficial tissues of the extremities, leading to an
nflammatory reaction.1,2 Genetic and dietary factors have
een implicated in increasing the level of MSU.2
Gout occurs in approximately 0.2–0.35 per 100 inhabitants
n the general population. The incidence is higher at the end
f the third/beginning of the fourth decade of life, predom-
nantly in males and in about 5% of women, usually after
enopause.2,3
Usually, the diagnosis is established by clinical and labo-
atory workup, and the reference method is the analysis of
ynovial fluid; however, this is an invasive technique. Thus,
he therapy can be started based on the diagnostic criteria of
he American College of Rheumatology (ACR).4 BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The importance of an accurate diagnosis and treatment of
gout should not be underestimated, because these patients
will depend on the therapy throughout their lives, in order
to diminish those morbidities associated with hyperuricemia.
Due to the multiple differential diagnoses, and also consider-
ing the atypical presentations of gout, imaging studies may be
useful in various stages of this disease.5
In the last decade, we  have witnessed important advances
in imaging techniques, assisting in the noninvasive diagnosis
and follow-up of patients being treated for gout. To the best
of our knowledge, no recent review of the imaging aspects for
gout was published in Brazilian literature. To the best of our
knowledge, there has not been any recently published review
of imaging aspects for gout in Brazilian literature. This review
aims to summarize recent advances in the literature related to
imaging studies, disclosing the relevant aspects to physicians
of all specialties with respect to the diagnosis and follow-up
of gout patients by imaging methods, in view of the increase
and the high prevalence of this disease.
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Methods
A search of major databases (Medline, Lilacs, Cochrane Library
and PubMed) was conducted with the use of the terms “gout,”
“arthritis,” “tophaceous gout” and “urate”. Our search was
limited to original articles published in the last 5 years, but
review articles and case reports of significant clinical relevance
were included in the survey.
More  than 700 articles and abstracts published on the
proposed topic in this review were identified in the search.
The selection was based on clinical importance; articles
that showed no relationship with diagnostic imaging were
excluded. At the end, 39 articles remained.
Discussion
Four distinct clinical phases are recognized: asymptomatic
hyperuricaemia, acute monophasic gout, recurrent acute
attacks with intercritical periods and chronic gout which is
often tophaceous1,2 (a sequence of such events is not manda-
tory and asymptomatic patients do not receive a diagnosis of
gout). In each of these phases, it is possible to use imaging
studies.
The typical clinical picture of cases of acute gouty arthritis
includes a painful acute monoarthritis of the first metatarsal
or knee, with local inflammation and swelling, in association
with elevated levels of uric acid.
Hyperuricemia is one of the clinical criteria for a diagnosis
of gout, but although this is the predominant risk factor for
this disease, elevated serum uric acid levels not always result
in deposition of crystals.6 Serum urate levels >6.8 mg/dl can
lead to precipitation and deposition of urate crystals in the
joints and soft tissues, but acute gout crisis can occur even
in patients with normal serum urate levels; in these cases
the clinical diagnosis is more  difficult, and the doctor can get
help through imaging methods. Imaging studies can also be
used in atypical presentations, for example, in cases involv-
ing unusual age groups or locations, with prolonged and less
intense symptoms at the time of presentation.5,6
The intercritical period is that following an acute episode
of a painful gout crisis, in which the patient remains asymp-
tomatic. Advances in imaging techniques showed that, in
patients in the intercritical period, it is possible to detect
tophaceous deposits in up to 50% of joints that have already
been affected by acute episodes.5 It has also been shown that
asymptomatic patients had tophaceous deposits in the spinal
column, detected by computed tomography (CT).7
Knowing that in many  cases patients, even when asymp-
tomatic, may have already tophaceous deposits not detected
clinically, it is worth questioning whether it is important to
evaluate early joint, bone and tendon damage – or even the
tophaceous load – through imaging exams during the inter-
critical phase. At this stage, the imaging evaluation, as far as
our knowledge goes, is not yet a recommended practice in the
literature.
A few years must elapse so that the tophus becomes clin-
ically evident after the first attack; rarely these formations
are identified during this first episode.1 Chronic tophaceous 2 0 1 7;5 7(1):64–72
gout is characterized clinically by the presence of tophi, which
are formed secondarily to the accumulation of uric acid, pro-
tein matrix, inflammatory cells and foreign body giant cells in
the tendons, ligaments, cartilages, bursae, subcutaneous cel-
lular tissue and in periarticular regions.5 The tophi are more
common on the extensor surfaces of the hands, elbows, feet,
knees, auricular appendages and the tip of the nose.
Although generally chronic tophaceous gout has a straight-
forward clinical diagnosis, in some cases the diagnosis can
be challenging, when the problem is associated with unusual
symptoms or with an atypical disease. Atypical clinical mani-
festations are seen more  frequently in certain segments of the
population, including the elderly, patients who have under-
gone organ transplants, and cancer patients.6
The tophi nodules can also not be typical, and the physi-
cian should take into account some differential diagnosis
as ganglion, cysts, bursitis, hematoma, amyloidosis, throm-
bophlebitis, sarcoidosis, psoriatic arthritis, pyrophosphate
deposit arthritis, neoplasms, tenosynovitis, rheumatoid nod-
ules, osteoarthritis and infection.8,9
At this stage, the imaging studies may be valid for the
assessment of disease severity, the extent of MSU  deposition,
and the presence of chronic inflammation. Moreover, images
may constitute a useful tool for monitoring the response to a
reduction of uric acid therapy.10
Monitoring  and  response  to  treatment
Several methods have been developed and evaluated by the
Outcomes Measures in Rheumatology (OMERACT) in order to
quantify tophi in patients with chronic tophaceous gout, from
the simplest methods, for instance, by physical examination,
to more  sophisticated means with the use of imaging tests.
In patients with a chronic tophaceous gout, quantification of
tophi and documentation of regression with treatment are
important measures of monitoring, in order to prevent joint
destruction. Patients with elevated levels of uric acid do not
necessarily exhibit higher masses of tophi, compared with
patients with low levels of uric acid.11,12
Among the methods using physical examination, the main
ones are number of tophi counting, physical measurement
with a measuring tape, the use of a specific instrument called
Vernier caliper, and digital photography.13
Ultrasound is a good tool for the evaluation of response to
treatment, thanks to its availability and also because it has
good sensitivity. The use of computed tomography and mag-
netic resonance imaging, although less available techniques,
results in some advantages, such as data storage possibility
for later reading and visualization of intra-articular tophi, in
the absence of subcutaneous tophi.14–16
Dual-energy CT (DECT) is emerging as a good tool because
with its use the physician can demonstrate MSU  deposits even
in asymptomatic patients. Although the ability of this tech-
nique in terms of quantifying tophi is a potentially useful
feature to evaluate small changes in tophus load and although
the technique plays a role in monitoring the response to treat-
ment, its cost and the radiation exposure (albeit low) mean
that the main role of DECT in monitoring treatment is limited
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o clinical trials of new therapeutic agents, with little use in
linical practice.16
mage  methods
he imaging methods used for the evaluation of gout are plain
adiography (X-ray), ultrasound (US), DECT, CT and magnetic
esonance imaging (MRI).
lain  radiography
loch et al.2 classified the radiological findings in early, inter-
ediate and late changes. Radiographic changes are more
requent in the feet, especially in the first metatarsopha-
angeal joint.2,10 In the initial presentation of gout, there is
o specific radiographic signs – only an increased soft tis-
ue volume and density. With X-rays, one cannot assess early
hanges of the soft tissues such as effusion, initial erosion,
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ig. 1 – (A) Anteroposterior radiography of feet of a patient with g
djacent to the first metatarsophalangeal (MTP) joint (arrow). On
rst metatarsal. (B) Detail of the previous image showing the hea
arked with an asterisk (*) with raised edges, and Martel’s sign 
he foot at the level of the first MTP  joint, showing the cortical bo
oint space of the hallux, the cartilage of the head of the first me
oating cartilage (small arrow), characterizing the double contou
urface (arrow) of the head of the first metatarsal, articular cartila
haracterizing the double contour sign. P, proximal; D, distal; TS,
xtensor hallucis tendon. 0 1 7;5  7(1):64–72 67
synovial hypertrophy, hypervascularization, or small tophi.
On the other hand, with MRI – which shows these changes
– is not always that the physician can establish an accu-
rate differentiation between gout and some of its differential
diagnosis.
X-ray is a fast method, and generally it is used in the first
investigation of gout. X-ray has low sensitivity for diagnosis,
and there may be a gap from 6 to 12 years for the finding
of radiological evidence.2 In 2008, Rettenbacher et al. found
a sensitivity of 31–55% and a specificity of 93% for X-ray in
the diagnosis of gout.17 In cases of chronic tophaceous gout,
radiographic signs include visualizing tophi as soft tissue or
intraosseous masses, whether or not containing calcifications;
and the presence of a non-demineralizing arthropathy accom-
panied by erosions presenting margins which may be sclerotic
or protruding. The Martel’s sign (Fig. 1) consists in the presence
of a protruding, salient bone edge separated from a tophus
and leaning on it.18,19 In X-ray, generally the joint space is
preserved until the disease is advanced.10
TE
CAB
∗
∗
out showing increased volume and density of soft tissues
e can also observe bone erosion in distal metaphysis of the
d of the first left metatarsal, evidencing bone erosion
(arrow). (C) Ultrasound image with longitudinal section of
ne of the head of first metatarsal (large arrow), the MTP
tatarsal (*) and a thin hyperechoic layer overlying the
r sign. (D) Detail of the previous image showing the bone
ge (*) and the thin hyperechoic layer (small arrow),
 subcutaneous tissue; ESP, phalangeal space of hallux; TE,
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According to Bloch,16 X-ray is a method with little use in
the evaluation of treatment, primarily by its low sensitivity in
detecting the disease in its early stages, but also, because it
is based on the presence of late findings, such as increases in
soft tissue, cortical erosions, and lytic injuries.
Ultrasound
The high resolution of US allows us to identify the various
forms of presentation of gout and its relationship with the
different tissues, helping in an early and noninvasive diag-
nosis, therapeutic decision and management of treatment. In
addition, US is a very useful method of assessing the extent
and measurement of lesions and in the involvement of adja-
cent structures, with low interobserver variability; besides, US
fulfill the necessary characteristics for the evaluation of ther-
apeutic response. As for histopathologic confirmation of gout,
US is also useful in guiding punctures or biopsies.19,20
US detects early changes in the soft tissues in cases of gout
and can be used especially when the clinical, laboratory and
radiographic studies are negative or inconclusive. There are
several other advantages with the use of this technology: it is
noninvasive, easy to repeat the exam, ability to differentiate
between solid versus cystic lesions, low cost, patient contact,
absence of ionizing radiation, the possibility of acquisition of
multiplanar and high-resolution images, dynamic assessment
of the joint and tendons, and effective guidance in invasive
procedures.9,19,21 Some studies comparing the sensitivity and
specificity of US versus X-ray showed that US is more  sensi-
tive and earlier that X-ray, because the sonographic changes
are present at earlier stages, in comparison to typical X-ray
signals.17,19,22
Sonographic aspects which are characteristic for the diag-
nosis of gout are the “double contour signal” (Fig. 1), which is
characterized by an irregular linear hyperechoic layer on the
superficial margin of the anechoic hyaline cartilage and par-
allel to the bone cortex, without a posterior acoustic shade.
In a Thiele’s 2007 study,19 this signal was observed in 92% of
patients with biopsy-confirmed gout, and none of the controls.
But patients with asymptomatic hyperuricemia may show
the sign of the double contour, observed in the study of Pineda
et al. in 25% of the metacarpophalangeal joints.20 Moreover,
p
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Fig. 2 – Fifth metatarsophalangeal. (A and B) Sonographic image
hyperechoic, nodule located in the soft tissues adjacent to the m
undefined by the attenuation of the acoustic beam. P, proximal; D 2 0 1 7;5 7(1):64–72
with the reduction of uric acid levels, this signal tends to dis-
appear in up to 7 months.22
In 2008, Rettenbacher et al.17 found sensitivity and speci-
ficity of respectively 80% and 75% for the bright hyperechoic
foci in synovial tissue (microtophi) and 79% and 95% for
hyperechoic areas for the diagnosis of gout. Considering the
presence of either of the two findings, ultrasound had a sensi-
tivity of 96% and specificity of 73%. The specificity is not higher
because punctate hyperechoic foci, which may represent
microtophi, can also be observed in cases of osteoarthritis,
rheumatoid arthritis and chondrocalcinosis.23
When the bright hyperechoic foci are seen in combination
with the double contour signal, the specificity reaches 100%,
but with a considerable reduction of sensitivity.24
In cases where the doctor depends on an imaging study,
the knowledge of the sonographic features of tophus is impor-
tant so that one can differentiate between tophaceous nodules
and nodules from other etiologies (Fig. 2). US uses criteria that
help to differentiate between nodules caused by cancer and
inflammatory and infectious processes. In 2003, Nalbant,10
comparing tophi nodules and rheumatoid nodules, showed
that 80% of tophi were heterogeneous and of these, 75%
were hyperechoic; furthermore, this author observed only 15%
of heterogeneity and hyperechogenicity in rheumatoid nod-
ules. The rheumatoid nodule is more  homogeneous and can
present a well-defined, hypoechoic central area due to the
occurrence of necrosis. Since rheumatoid nodules rarely cal-
cify, this feature also helps to differentiate these formations
from tophi, which can calcify.
The presence of calcifications with posterior acoustic shad-
owing and irregularities of the cortical bone underlying to
nodules also favor a diagnosis of tophi. There is no correlation
between disease duration and the presence of calcifications
in tophi. The tophi are hyperechoic in 96.3% and hypoe-
choic in 3.7% of cases.12 The hyperechogenicity noted in tophi
represents deposits of urate or calcifications. Small hyper-
echoic particles, or bright foci, measure less than 1 mm  in
size and represent synovial microtophi.17 An agglomerate of
microtophi form hyperechoic the tophus; therefore, hyper-
echogenicity and heterogeneity are strong indicators of a
tophus.
The hypoechoic halo in tophus periphery is a hypoechoic
band observed partially or completely around the tophus and
B
tr
. Longitudinal (A) and cross (B) sections of an amorphous,
etatarsocuboid joint. The structures deep to the node are
, distal.
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ay correspond to inflammation, fibrosis or edema. This halo
s observed in large parts of tophi and can be a marker for
ophaceous nodule.12
The sonographic features of tophi in relation to the tendons
ay help to explain the clinical pictures showing movement
estrictions of patients with chronic tophaceous gout; further-
ore, their knowledge can avoid invasive procedures, such as
iopsies. A five-type classification of the relationship between
ophi and the tendon in patients with chronic tophaceous gout
as proposed,25 based on their location: tendon surrounded
y tophi, no relationship between tophus and tendon, tophi in
he tendon insertion site (enthesopathy), extrinsic compres-
ion, and tophi within the tendon.
Enthesopathy secondary to tophi is a recent finding in the
iterature; and although it has been described in only 7% of
ases of chronic tophaceous gout, this possibility should be
onsidered in the differential diagnosis, depending on the
linical context. The differential diagnosis of enthesopathy
s broad and includes calcium pyrophosphate deposition dis-
ase, degenerative disease, acromegaly, hyperparathyroidism,
ypoparathyroidism, and rheumatoid arthritis, among others.
he intratendinous tophus tends to evolve to the rupture of
he tendon26 and an early sonographic diagnosis may assist
he physician in establishing an effective treatment while
voiding damage that, if not treated medically, may evolve
nto the need for surgical treatment. Inside the tendon, the
ophi may have microdeposits demonstrated by bright, ovoid
nd hyperechoic spots. Chronic intratendinous tophi can be
videnced as hyperechoic bands, occasionally accompanied
y a posterior acoustic shadow.27
US allows the visualization of the changes in the inflamma-
ory process of gout. The evaluation of gout by color Doppler
T
A
B
T 
ig. 3 – (A) sonographic image in the longitudinal plane in the fir
outy crisis. One can observe the presence of bone erosions (//) a
hows increased vascularity in tophi. Cortical bone (arrows). 0 1 7;5  7(1):64–72 69
US demonstrates increased flow in the acute phase of the
podagra crisis, which normalizes partially in 7 days. Gener-
ally, color shows no flow when the patient is out of the gout
crisis,10 but in the author’s practice it has been observed that
painful periarticular areas in patients with a known diagnosis
of gout can exhibit hyperechoic tophi and flow with Doppler,
even without the classic signs of crisis, which explains the
atypical clinical pictures of gouty arthralgia. However, these
findings depend on further studies to justify their use (Fig. 3).
Bone erosions are defined as cortical discontinuities
observed in two perpendicular planes. This is a late finding
and has low sensitivity in diagnosing tophaceous gout; how-
ever, these erosions are slightly better detected by US versus
X-ray (24% versus 20% of cases).17
The dimensions of the gouty tophus assume importance
in assessing the response to treatment; therefore, in order
to acquire practical utility, the method used for this purpose
must show a good reproducibility. Perez-Ruiz et al. showed
that US is able to detect all periarticular tophi identified by
MRI.10,28 After the publication of these studies, OMERACT has
considered US as a possibly useful method in measuring gouty
tophi; but new clinical trials must be conducted for validation
of this method.
Computed  tomography  (CT)
CT allows the visualization of tophi in both the subcutaneous
tissue and in intra-articular areas. This method also helps to
identify bone erosion, being more  sensitive than X-ray and MRI
for this purpose. A systematic analysis showed that CT detects
the presence of intraosseous tophi in 81% of joints presenting
T
Erosoes
T
st metacarpal. Patient with pain without evidence of a
nd tophi (T) adjacent to the erosions. (B) The color Doppler
 t o l .70  r e v b r a s r e u m a
erosion and in 100% of cases when the erosion is greater than
7.5 mm.29
CT can also reveal MSU  deposits inside tophi, thanks to its
attenuation close to 160 UH, compared to calcium deposits,
which have higher attenuation, around 450 UH.30 Thus, CT
can assist in the differentiation with respect to other types of
soft tissue nodules. CT can be used as a complementary imag-
ing method in the evaluation of damage to deeper structures,
when methods that do not use ionizing radiation could not
confirm its presence. In cases of involvement of deep struc-
tures such as the spine, possibly CT can complement an MRI
study, by demonstrating masses of tophi with compression of
nerve structures.
While it may be useful, CT is not recommended as a method
of choice in the evaluation of gout on surface structures due
to the ionizing radiation exposure.
Dual-energy  computed  tomography  (DECT)
DECT is a method that provides information about the chem-
ical composition of tissues and allows their differentiation.
Through this technique, it is possible to distinguish MSU crys-
tals from gout, bone or dystrophic calcification.6 In some
studies examining the deposition of articular and periartic-
ular crystals using DECT, high sensitivity and specificity were
observed. Variations on the data obtained could be due to the
different joints evaluated, protocols used and different stages
of this disease.30–34
In the early stages of the disease when the MSU deposits
are microscopic and with an intra-articular location, not being
macroscopic tophi, DECT may not be able to detect them, since
this technique has a size threshold, usually of 2 mm – the
technique is not able to distinguish deposits with dimensions
below this limit.35 In addition to the limitations related to the
size of deposits, DECT is susceptible to some artifacts, mainly
related to metallic devices, calluses, nails and thickened skin
areas such as that in the heel.
Most studies did not explore the diagnostic accuracy
of DECT in the first presentation of gouty arthritis. Based
on limited published data, in the first episode of gouty
Fig. 4 – MRI  images of the foot on the long (A) and short (B) axis,
metatarsophalangeal joint, in association with a pattern of medu
fifth metatarsal (*), as well as a densification of the adjacent fat p 2 0 1 7;5 7(1):64–72
arthritis, the diagnostic sensitivity is low, around 50%.36 In
a study of 21 patients comparing the diagnostic accuracy of
US versus DECT in cases with suspected gout, the authors
observed similar sensitivity in these two methods, with false-
negative results in DECT accurately detected with US.16
DECT may be used to assess gout, regardless of serum
uric acid levels, and can confirm the disease in patients with
normal serum uric acid levels, or exclude it in patients with
hyperuricemia. The general burden or uric acid deposition
volume may be calculated on individual lesions, joints, or in
the entirely digitalized area. A possible disadvantage of DECT
could be the patient’s exposure to ionizing radiation, but the
dose is less than the natural annual dose received and much
lower than the potentially malignancy-inducing values.22 Due
to the cost and to the radiation exposure (albeit low), its main
role, monitoring the treatment, is limited to clinical trials of
new therapeutic agents, more  than in clinical practice.16
Magnetic  resonance
MRI is not routinely used to evaluate tophaceous gout. This
technique can be used to recognize the cause of motion lim-
itations, motor or painful disorders secondary to changes in
deep structures or that are coated with bone; in such event,
the access through US is not suitable (Fig. 4).
MRI is also useful for assessing the differential diagnosis
of soft tissue masses on the extremities.31 In MRI  studies,
usually the tophus presents itself as a juxta-articular mass
of soft tissue, causing periarticular erosions and synovial
thickening. Using this technique, the appearance of tophi is
variable. In T2-weighted sequence, there is a variation of a low-
to-high signal, with a homogeneous or non-homogeneous
pattern, depending on the degree of hydration and calci-
fication. The most common appearance in a T2-weighted
sequence is a low-to-intermediate, heterogeneous signal. In
a T1-weighted sequence, its appearance is more  consis-
tent, generally exhibiting a low-to intermediate signal. The
enhancement pattern is also variable. Another feature is the
enhancement surrounding the tophus; probably this is related
to the adjacent granulation tissue (Fig. 5).37
 showing joint effusion (arrow) in the fifth
llary bone edema in the head and distal metaphysis of the
lanes (arrowhead).
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Fig. 5 – Sagittal MRI  images: T1-weighted (A), T2-weighted (B), axial T2-weighted (C) and sagittal after contrast (D) images of
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eterogeneous enhancement after IV injection of paramagn
MRI  also provides information on the morphology of tophi,
hich can range from small nodular masses deposited in
oorly defined anatomical planes, even with a permeative
spect.38
Perez-Ruiz et al. evaluated the measurement of tophi in
 comparison between US and MRI, including the change in
ophus size and its association with serum concentrations of
rate in the course of 12 months. In this study, the diameters
valuated in MRI  were larger than those obtained with the use
f US, and this may be related to better MRI  imaging for the soft
issue component of the tophus, which can contain regions of
nflammation and hypervascularity.10
Recent studies have shown that MRI  can detect early artic-
lar erosions that are not radiographically apparent.39 Faced
ith an acute gouty arthritis, it is common the occurrence
f periarticular edema, synovitis, and joint effusion, as well as
he presence of a high signal in bone marrow and periarticular
oft tissues; but these changes can be seen in any inflamma-
ory arthropathy, thus being unspecific findings. MRI is not a
elevant technique to help in the establishment of the initial
iagnosis of gout. For these reasons, MRI  should not be rou-
inely used for the diagnosis of gout in its early stages, both in
ases of typical clinical presentation, as in atypical cases.eterogeneous hyperintense signal on T2, with
ontrast in the dorsal aspect of the foot (arrows).
Conclusion
Imaging methods can be useful to aid in the diagnosis and
monitoring of treatment of patients with gout and, in partic-
ular, the use of ultrasound, which is an available, noninvasive
tool which provides good results. The potential of ultrasound
diagnosis has increased the interest among physicians. This
is a readily available, non-invasive tool that can be used for
the investigation of this disease.
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